• News
  • SAN DIEGO
  • Finance

Mallinckrodt buying Cadence Pharma for $1.21B

The health care products company Mallinckrodt is buying Cadence Pharmaceuticals for about $1.21 billion in a bid to strengthen its specialty drugs unit.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!